| Literature DB >> 29387384 |
Masoud Soosaraei1, Ali Akbar Khasseh2, Mahdi Fakhar3, Hajar Ziaei Hezarjaribi3.
Abstract
BACKGROUND: Leishmaniasis is an extremely relevant tropical disease, with global distribution. It still remains a main public health concern in low-income countries, and it is necessary to support more research on this common disease. Thus, a bibliometric analysis of the global scientific production on leishmaniasis was carried out.Entities:
Keywords: Bibliometric; International collaboration; Leishmania; Network analysis; Web of Science
Year: 2018 PMID: 29387384 PMCID: PMC5771967 DOI: 10.1016/j.amsu.2017.12.014
Source DB: PubMed Journal: Ann Med Surg (Lond) ISSN: 2049-0801
Fig. 1Quantitative growth process of the studies concerning leishmaniasis in the period of ten years.
Most cited global research in the field of Leishmania.
| Principal authors | Title | Publication year | Country | Institutional affiliation | Journal | No. of citations | |
|---|---|---|---|---|---|---|---|
| 1 | Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M. | Leishmaniasis worldwide and global estimates of its incidence. | 2012 | Switzerland | Department for the Control of Neglected Tropical Diseases (HTM/NTD/IDM), Leishmaniasis Control Program, World Health Organization, Geneva, Switzerland. | PloS one | 913 |
| 2 | Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, Flynn BJ, Hoff ST, Andersen P, Reed SG, Morris SL, Roederer M, Seder RA. | Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. | 2007 | USA | Cellular Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), 40 Convent Drive, Bethesda, Maryland 20892, USA | Nature medicine | 748 |
| 3 | Seder RA, Darrah PA, Roederer, M. | T-cell quality in memory and protection: implications for vaccine design. | 2008 | USA | Cellular Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), 40 Convent Drive, Bethesda, Maryland 20892, USA | Nature Reviews Immunology | 708 |
| 4 | Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, Cross R, Sehy D, Blumberg RS, Vignali DA. | The inhibitory cytokine IL-35 contributes to regulatory T-cell function | 2007 | USA | Department of Immunology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. | Nature | 700 |
| 5 | Croft SL, Sundar S, Fairlamb AH. | Drug resistance in leishmaniasis | 2006 | Switzerland | Drugs for Neglected Diseases Initiative, 1 Place Saint-Gervais, CH-1201 Geneva, Switzerland. | Clinical microbiology reviews | 666 |
Most productive researchers in the field of Leishmania.
| Author name | No. of articles |
|---|---|
| Sundar S | 232 |
| Das P | 144 |
| Boelaert M | 120 |
| Dujardin JC | 120 |
| Mohebali M | 98 |
| Kaiser M | 94 |
| Brun R | 93 |
| Khamesipour A | 85 |
| Dube A | 85 |
| Gupta S | 83 |
Top researchers based on H-index in the field of Leishmania.
| Rank | Author name | All articles | All citations | H-index |
|---|---|---|---|---|
| 1 | Sundar S | 232 | 6212 | 38 |
| 2 | Dujardin JC | 120 | 3508 | 32 |
| 3 | Boelaert M | 120 | 3129 | 29 |
| 4 | Rijal S | 79 | 2210 | 26 |
| 5 | Brun R | 93 | 2055 | 25 |
| 6 | Fairlamb AH | 42 | 1789 | 23 |
| 7 | Ouellette M | 59 | 1434 | 23 |
| 8 | Volf P | 78 | 1283 | 23 |
| 9 | Wilson ME | 57 | 1083 | 23 |
| 10 | Schonian G | 65 | 1617 | 22 |
| 11 | Coombs GH | 53 | 1384 | 22 |
| 12 | Reed SG | 48 | 1826 | 21 |
| 13 | Mottram JC | 57 | 1751 | 21 |
| 14 | Kamhawi S | 42 | 1613 | 21 |
| 15 | Kaiser M | 94 | 1372 | 21 |
Fig. 210 leading countries in the studies concerning leishmaniasis.
Ten primary organizations in the field of Leishmania.
| Organization name | All articles | Percent of all records |
|---|---|---|
| FUNDACAO OSWALDO CRUZ | 1207 | 8.8% |
| UNIVERSIDADE DE SAO PAULO | 641 | 4.69% |
| UNIVERSIDADE FEDERAL DE MINAS GERAIS | 478 | 3.49% |
| LE RESEAU INTERNATIONAL DES INSTITUTS PASTEUR RIIP | 411 | 3% |
| UNIVERSIDADE FEDERAL DO RIO DE JANEIRO | 394 | 2.88% |
| COUNCIL OF SCIENTIFIC INDUSTRIAL RESEARCH CSIR INDIA | 345 | 2.52% |
| CENTERRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS | 333 | 2.45% |
| TEHRAN UNIVERSITY OF MEDICAL SCIENCES | 321 | 2.35% |
| UNIVERSITY OF LONDON | 316 | 2.31% |
| NATIONAL INSTITUTES OF HEALTH NIH USA | 273 | 1.99% |
Fig. 3The cooperation of different scholars in Iran with other regions in the world.
Fig. 4Cooperation full network between different countries in the field of leishmaniasis.
Most frequent words used in the title of Leishmania studies in Iran and the world.
| Rank | World | Iran | ||
|---|---|---|---|---|
| Term | Occurrences | Term | Occurrences | |
| 1 | Brazil | 569 | Leishmaniasis | 265 |
| 2 | Activity | 557 | Iran | 213 |
| 3 | Treatment | 493 | Effect | 53 |
| 4 | Diptera | 450 | Evaluation | 43 |
| 5 | Psychodidae | 437 | Treatment | 40 |
| 6 | Synthesis | 418 | Balb/c mouse | 33 |
| 7 | Area | 325 | Diagnosis | 28 |
| 8 | Response | 315 | Zoonotic cutaneous leishmaniasis | 28 |
| 9 | State | 312 | Expression | 27 |
| 10 | Expression | 282 | Dog | 21 |
| 11 | Macrophage | 255 | Psychodidae | 21 |
| 12 | Cell | 227 | Diptera | 19 |
| 13 | Antileishmanial activity | 215 | Synthesis | 19 |
| 14 | Immune response | 209 | Efficacy | 18 |
| 15 | Efficacy | 199 | Immune response | 18 |
| 16 | In vitro | 198 | Protection | 17 |
| 17 | Mouse | 195 | In vitro | 16 |
| 18 | Derivative | 191 | Balb/c | 15 |
| 19 | India | 176 | Glucantime | 15 |
| 20 | Resistance | 166 | MRHO/IR (strain) | 15 |
Fig. 5Density view of the most frequent terms used in the global studies concerning leishmaniasis.
Fig. 6Density view of the most frequent terms used in Iranian studies concerning leishmaniasis.
Fig. 7Word cloud of global research keywords of Leishmania.
Fig. 8Word cloud of Iranian research keywords of Leishmania.